Ursula Vogl

9PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersMolecular targetsClinical pharmacology and therapeuticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 11, 2025
Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early Variations.

Giuseppe Salfi, Martino Pedrani, Amos Colombo

|Jun 13, 2025
Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive Setting.

Martino Pedrani, Giuseppe Salfi, Sara Merler

|Jan 11, 2025
The Emerging Predictive and Prognostic Role of Aggressive-Variant-Associated Tumor Suppressor Genes Across Prostate Cancer Stages.

Martino Pedrani, Jessica Barizzi, Giuseppe Salfi

|Sep 28, 2024
Oligometastatic Urothelial Cancer and Stereotactic Body Radiotherapy: A Systematic Review and an Updated Insight of Current Evidence and Future Directions.

Antonio Angrisani, Davide Giovanni Bosetti, Ursula Maria Vogl

|Jan 23, 2024
Antiandrogens as Therapies for COVID-19: A Systematic Review.

Massimiliano Cani, Samantha Epistolio, Giulia Dazio

|Jan 11, 2024
Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer.

Mariangela Calabrese, Isabella Saporita, Fabio Turco

Pageof 2

Frequent Collaborators

4 joint publications

Giuseppe Salfi

4 joint publications

Ricardo Pereira Mestre

4 joint publications

Martino Pedrani

3 joint publications

Consuelo Buttigliero